Skip to content

Vestibular Infants Screening-Flanders

Implementation of a Standard Vestibular Screening Protocol for Hearing-impaired Infants in Flanders

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05061069
Acronym
VIS-Flanders
Enrollment
301
Registered
2021-09-29
Start date
2018-06-01
Completion date
2022-08-11
Last updated
2025-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hearing Impaired Children, Vestibular Disorder

Keywords

vestibular, balance, hearing loss, infants

Brief summary

Hearing-impaired children are at risk for a vestibular impairment, as the auditory and vestibular end organs are closely related. Although this can compromise a child's development on many levels, vestibular testing is not routinely performed in this vulnerable group. This project aims to give each congenitally hearing-impaired child in Flanders (Belgium) access to a basic vestibular screening at a young age and set an example for other regions worldwide.

Detailed description

The implementation of a vestibular screening in hearing-impaired babies of six months old will timely discover vestibular problems to limit the impact on the (motor) development. The cervical vestibular evoked myogenic potential (cVEMP) technique will be used as a vestibular screening tool. Flanders is the first region worldwide that will implement a vestibular screening. All official Flemish reference centres of Kind en Gezin (Child and Family) will participate in this project. Study purpose: The final utilisation goal of this project is to limit the impact of a vestibular dysfunction on the (motor) development of children. Since hearing-impaired children have a higher risk for deficits of the vestibular (balance) organ, the researchers will focus on this vulnerable group. This will be accomplished by: * The implementation of a standard vestibular screening protocol in Flanders in hearing-impaired children at the age of 6 months, enabling early diagnosis of vestibular deficits and adequate referral for extensive vestibular testing, motor assessment and rehabilitation. * Increasing the awareness for vestibular dysfunctions and its associated symptoms in hearing-impaired children among parents, teachers, paramedics, specialists and other social workers who are in close contact with hearing-impaired children. This should go hand in hand with more effective patient care, because adequate therapy will start sooner. Methodology: The aim of the project is to add a vestibular screening to the existing auditory screening programme (MAICO test). The following steps will be performed to guarantee an accurate vestibular follow-up in Flemish hearing-impaired children: * In case of a 'refer' on the second MAICO test, Kind en Gezin (Child and Family) will refer the child to the reference centres of Kind en Gezin in Flanders. * These reference centres will perform a diagnostic hearing test (brainstem evoked response audiometry: BERA) to confirm the permanent hearing loss (standard of care). * Each child with a confirmed hearing loss (BERA 'refer') will be subjected to a vestibular screening at the age of six months (on average 120/year), combined with tympanometry, in that specific reference centre at the age of six months. The cervical vestibular evoked myogenic potential (cVEMP) technique will be used. * In case of a refer on the vestibular screening (cVEMP 'refer'), the reference centres will refer the child for motor assessment and, if necessary, for rehabilitation.

Interventions

DIAGNOSTIC_TESTcervical vestibular evoked myogenic potentials (cVEMP)

cVEMPs are ipsilateral, short latency, inhibitory myogenic potentials that assess otolith (mainly saccular) function and the integrity of the inferior branch of the vestibular nerve.

Sponsors

Universitair Ziekenhuis Brussel
CollaboratorOTHER
Universitaire Ziekenhuizen KU Leuven
CollaboratorOTHER
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
CollaboratorOTHER
Queen Fabiola Children's University Hospital
CollaboratorOTHER
AZ Turnhout
CollaboratorOTHER
Gasthuis Zusters Antwerpen
CollaboratorOTHER
GZA Ziekenhuizen Campus Sint-Augustinus
CollaboratorOTHER
University Hospital, Antwerp
CollaboratorOTHER
Jessa Hospital
CollaboratorOTHER
Ziekenhuis Oost-Limburg
CollaboratorOTHER
Algemeen Stedelijk Ziekenhuis
CollaboratorOTHER
Algemeen Ziekenhuis Maria Middelares
CollaboratorOTHER
AZ Delta
CollaboratorOTHER
AZ Sint-Jan AV
CollaboratorOTHER
AZ Sint-Lucas Brugge
CollaboratorOTHER
Sint-Lievenspoort Gent
CollaboratorUNKNOWN
Center for Developmental and Hearing Disorders
CollaboratorUNKNOWN
University Hospital, Ghent
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

Multicenter non-commercial interventional academic research

Eligibility

Sex/Gender
ALL
Age
4 Months to 24 Months
Healthy volunteers
No

Inclusion criteria

* Flemish children with permanent congenital or delayed-onset hearing loss, which occurred before the age of 9 months, are included.

Exclusion criteria

* Children with temporary hearing loss (e.g. due to otitis media) are excluded.

Design outcomes

Primary

MeasureTime frameDescription
Number of Hearing-impaired Infants in Flanders With Abnormal Vestibular Screening Results.Each infants will be subjected to the screening at the age of six months. In case of inconclusive results during the first screening, the screening will be repeated within three months after the first screening moment.The primary outcome measure is the number of hearing-impaired infants in Flanders with abnormal vestibular screening results according to the degree, laterality, and onset of hearing loss. Abnormality of the vestibular screening results is based on the rectified interpeak amplitude values of the cVEMP (cervical vestibular evoked myogenic potentials) responses.

Countries

Belgium

Participant flow

Recruitment details

The vestibular screening was offered to all Flemish infants with permanent hearing loss around the age of 6 months in 1 of the 25 reference centers involved in the UNHSP.

Participants by arm

ArmCount
Infants With Permanent Hearing Loss
Each infant with permanent hearing loss in Flanders will be offered a vestibular screening by means of the cVEMP (cervical vestibular evoked myogenic potentials) test to screen for vestibular deficits. cervical vestibular evoked myogenic potentials (cVEMP): cVEMPs are ipsilateral, short latency, inhibitory myogenic potentials that assess otolith (mainly saccular) function and the integrity of the inferior branch of the vestibular nerve.
301
Total301

Baseline characteristics

CharacteristicInfants With Permanent Hearing Loss
Age, Categorical
<=18 years
301 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
Age, Continuous7.4 months
STANDARD_DEVIATION 2.4
Infant with permanent hearing loss301 Participants
Race and Ethnicity Not Collected— Participants
Region of Enrollment
Belgium
301 participants
Sex: Female, Male
Female
153 Participants
Sex: Female, Male
Male
148 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 0
other
Total, other adverse events
0 / 0
serious
Total, serious adverse events
0 / 0

Outcome results

Primary

Number of Hearing-impaired Infants in Flanders With Abnormal Vestibular Screening Results.

The primary outcome measure is the number of hearing-impaired infants in Flanders with abnormal vestibular screening results according to the degree, laterality, and onset of hearing loss. Abnormality of the vestibular screening results is based on the rectified interpeak amplitude values of the cVEMP (cervical vestibular evoked myogenic potentials) responses.

Time frame: Each infants will be subjected to the screening at the age of six months. In case of inconclusive results during the first screening, the screening will be repeated within three months after the first screening moment.

Population: Overall, 301 infants were screened, of which 47 infants were excluded for data analysis.~Excluded infants:~Bilateral normal hearing during audiological follow-up: n = 9 Parents declined retest in case of initial inconclusive results: n = 6 Delayed-onset hearing loss after ten months of age: n = 1 Permanent conductive hearing loss due to external auditory canal atresia: n = 22 Parents gave consent to perform the cVEMP, but did not give consent to analyze and include the data: n = 9

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Infants With Permanent Hearing LossNumber of Hearing-impaired Infants in Flanders With Abnormal Vestibular Screening Results.35 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026